HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoko Takahashi Selected Research

3-cyanoalanine

7/2010Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain.
11/2007Hydrogen sulfide as a novel nociceptive messenger.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoko Takahashi Research Topics

Disease

19Neoplasms (Cancer)
11/2021 - 10/2002
7Inflammation (Inflammations)
01/2022 - 11/2007
5Asthma (Bronchial Asthma)
01/2022 - 01/2018
4Infections
01/2020 - 01/2016
4Melanoma (Melanoma, Malignant)
12/2018 - 02/2002
4Diabetes Mellitus
01/2015 - 01/2004
4Hyperalgesia
01/2013 - 11/2007
3Obesity
10/2022 - 01/2008
3Carcinoma (Carcinomatosis)
01/2022 - 07/2019
3Virus Diseases (Viral Diseases)
02/2020 - 01/2018
3Heart Failure
01/2020 - 02/2010
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2019 - 12/2003
2Frailty
02/2022 - 01/2021
2Hypoxia (Hypoxemia)
01/2022 - 07/2019
2Respiratory Hypersensitivity
01/2022 - 11/2018
2Hernia (Hernias)
01/2022 - 08/2021
2Hypersensitivity (Allergy)
01/2020 - 10/2018
2Adenocarcinoma
04/2018 - 03/2009
2Acne Vulgaris
01/2017 - 11/2002
2Proteinuria
01/2015 - 08/2011
2Neuralgia (Stump Neuralgia)
01/2013 - 07/2010
2Lymphoma (Lymphomas)
05/2009 - 12/2005
1Shoulder Injuries
12/2022
1Pediatric Obesity
10/2022
1Prolapse
08/2022
1Noncommunicable Diseases
08/2022
1Hemorrhoids
08/2022
1False Aneurysm (Pseudoaneurysm)
01/2022
1Histiocytic Sarcoma
11/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2021
1Thromboembolism
11/2021
1Squamous Cell Neoplasms (Squamous Cell Cancer)
10/2021
1Esophageal Neoplasms (Esophageal Cancer)
10/2021
1Cross Infection (Nosocomial Infection)
10/2021
1Rectocele
08/2021
1Cognitive Dysfunction
01/2021
1Ovarian Epithelial Carcinoma
01/2021
1Rhinosinusitis
01/2021
1Impetigo (Impetigo Contagiosa)
03/2020

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2007
5Telomerase (Telomerase Reverse Transcriptase)IBA
01/2016 - 11/2003
3Opioid Receptors (Opioid Receptor)IBA
01/2022 - 01/2013
3Immunoglobulin E (IgE)IBA
01/2020 - 01/2018
3SteroidsIBA
10/2018 - 02/2010
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2018 - 06/2016
3Messenger RNA (mRNA)IBA
03/2018 - 11/2003
3Pharmaceutical PreparationsIBA
05/2017 - 02/2007
3Hydrogen Sulfide (Sulfide, Hydrogen)IBA
07/2010 - 11/2007
3Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
09/2009 - 12/2003
2MicroRNAs (MicroRNA)IBA
10/2022 - 01/2020
2Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2021
2Methacholine Chloride (Methacholine)FDA Link
01/2022 - 11/2018
2OvalbuminIBA
01/2022 - 01/2020
2Prednisolone (Predate)FDA LinkGeneric
11/2021 - 08/2011
2Thromboplastin (Tissue Factor)IBA
11/2021 - 01/2021
2CytokinesIBA
01/2021 - 01/2018
2OligodeoxyribonucleotidesIBA
01/2020 - 03/2009
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2020 - 01/2018
2AllergensIBA
01/2020 - 01/2018
2IronIBA
01/2019 - 02/2010
2AntigensIBA
11/2018 - 10/2002
2GlucocorticoidsIBA
10/2018 - 01/2018
2LigandsIBA
11/2017 - 11/2017
2Adrenal Cortex Hormones (Corticosteroids)IBA
05/2017 - 12/2006
2AgarIBA
01/2016 - 11/2003
2Hyaluronic Acid (Hyaluronan)IBA
01/2015 - 09/2009
2NeuropeptidesIBA
10/2011 - 03/2006
2MibefradilIBA
07/2010 - 11/2007
2T-Type Calcium Channels (T-Type Calcium Channel)IBA
07/2010 - 03/2009
2propargylglycineIBA
07/2010 - 11/2007
23-cyanoalanineIBA
07/2010 - 11/2007
2EnzymesIBA
02/2010 - 11/2007
2sodium bisulfide (NaHS)IBA
03/2009 - 11/2007
2GasotransmittersIBA
03/2009 - 11/2007
2CollagenIBA
01/2009 - 06/2008
2RetinoidsIBA
08/2006 - 02/2002
1Herpes Zoster VaccineIBA
12/2022
1Environmental Pollutants (Pollutants, Environmental)IBA
08/2022
1Analgesics (Analgesic Drugs)IBA
08/2022
1aluminum sulfate (alum)IBA
08/2022
1Sclerosing Solutions (Sclerosing Agents)IBA
08/2022
1Tannic AcidFDA Link
08/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1Interleukin-4 (Interleukin 4)IBA
01/2022
1N-methylnaloxoneIBA
01/2022
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2022
1Blood Coagulation Factors (Coagulation Factor)IBA
11/2021
1Circulating Tumor DNAIBA
10/2021
1ORALIT (ORS)IBA
10/2021
1Peptide Hydrolases (Proteases)FDA Link
01/2021
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
01/2021

Therapy/Procedure

12Therapeutics
08/2022 - 11/2002
3Drug Therapy (Chemotherapy)
11/2021 - 08/2011
3Blood Component Removal (Apheresis)
03/2020 - 01/2017
2Polypharmacy
02/2022 - 01/2021
2Hysterectomy
01/2022 - 08/2021
1Sclerotherapy
08/2022
1Stents
01/2022
1Radiotherapy
11/2021
1Operative Surgical Procedures
10/2021